Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China
Yiqun Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Dainan Zhang(University of Electronic Science and Technology of China), Peng Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongnan Mo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiayu Wang(Second Hospital of Shandong University), Qing Li(Army Medical University), Shanshan Chen(Chongqing University of Posts and Telecommunications), Ye Zhang(University of Electronic Science and Technology of China), Yang Luo(Chongqing University of Posts and Telecommunications), Yimeng Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Zijing Wang(Qingdao University), Qiao Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Pin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Fan(Hebei North University), Shaoyan Lin(Nanjing Agricultural University), Xiuwen Guan(Chinese Academy of Medical Sciences & Peking Union Medical College), Ruigang Cai(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Ma(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 21
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k